Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer
A novel workflow to enrich and isolate patient-matched EpCAM high and EpCAM low/negative CTCs enables the comparative characterization of the PIK3CA status in metastatic breast cancer
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells